A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms.
作者信息
Bouligny Ian M, Montalban-Bravo Guillermo, Sasaki Koji, Daver Naval, Jabbour Elias, Alvarado Yesid, DiNardo Courtney D, Ravandi Farhad, Borthakur Gautam, Pemmaraju Naveen, Kadia Tapan, Masarova Lucia, Takahashi Koichi, Andreeff Michael, Bazinet Alexandre, Yang Hui, Kanagal Rashmi, Pierce Sherry, Meyer Meghan, Huang Xuelin, Garcia-Manero Guillermo
机构信息
The University of Texas MD Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
The University of Texas MD Anderson Cancer Center, Department of Hematopathology, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
出版信息
Leukemia. 2025 Feb;39(2):524-528. doi: 10.1038/s41375-024-02457-7. Epub 2024 Nov 17.
PMID:39551874
Abstract
摘要
Zotero 插件